Our wound pathogen assay utilizes the latest in quantitative RT-PCR (real-time reverse transcription polymerase chain reaction) technology to rapidly and reliably analyze your patient's sample.
PCR provides the greatest sensitivity and specificity with the ability to rapidly detect and differentiate 98% to 99% of the most common aerobic, anaerobic, and facultative bacteria, viral and fungal targets, and polymicrobial infections.
Our universal medium eliminates the need for specialized live sample handling or storage by safely inactivating and stabilizing the sample in transport for subsequent analysis. This reduces the impact of transport time and cost.
Use the latest in molecular diagnostic technology to diagnose wounds that are slow to heal including:
• Diabetic ulcers
• Pressure sores
• Venous ulcers
ACCREDITATIONS
Pennsylvania: #38140
Rhode Island: #LCO01417
Maryland: #3217
New Jersey: #00064758
California: #CDS-90002602
TX CLIA: 45D2108966